[Update on research and development of substances with antimicrobial potential].

Q3 Medicine
Kateřina Bogdanová, Kristýna Rešová, Milan Kolář
{"title":"[Update on research and development of substances with antimicrobial potential].","authors":"Kateřina Bogdanová, Kristýna Rešová, Milan Kolář","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Antibiotics have been considered miracle drugs since the widespread introduction of penicillin, an antimicrobial substance with the potential to save millions of lives. Unfortunately, their excessive use, especially in agriculture and health care, has resulted in the selection and spread of resistant bacterial strains. The accelerated occurrence of antimicrobial resistance is currently a serious global problem, regardless of the level of economic development of individual countries. For this reason, great pressure is placed on developing new substances with an antimicrobial effect or modifying existing antimicrobials. A rational antibiotic policy and antibiotic stewardship are applied to preserve the effectiveness of current antibiotics for as long as possible. The article aims to introduce the readers to some of the newly developed antimicrobial agents that have the potential for possible clinical use: lipophosphonoxins, recently developed antimicrobial agents acting on the bacterial cytoplasmic membrane; silver nanoparticles and their antimicrobial effect on multidrug-resistant bacteria, either in their pure form or in combination with antibiotics or photodynamically active substances; and some phytoextracts, substances of plant origin with proven antibacterial activity.</p>","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"30 4","pages":"110-116"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicka mikrobiologie a infekcni lekarstvi","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Antibiotics have been considered miracle drugs since the widespread introduction of penicillin, an antimicrobial substance with the potential to save millions of lives. Unfortunately, their excessive use, especially in agriculture and health care, has resulted in the selection and spread of resistant bacterial strains. The accelerated occurrence of antimicrobial resistance is currently a serious global problem, regardless of the level of economic development of individual countries. For this reason, great pressure is placed on developing new substances with an antimicrobial effect or modifying existing antimicrobials. A rational antibiotic policy and antibiotic stewardship are applied to preserve the effectiveness of current antibiotics for as long as possible. The article aims to introduce the readers to some of the newly developed antimicrobial agents that have the potential for possible clinical use: lipophosphonoxins, recently developed antimicrobial agents acting on the bacterial cytoplasmic membrane; silver nanoparticles and their antimicrobial effect on multidrug-resistant bacteria, either in their pure form or in combination with antibiotics or photodynamically active substances; and some phytoextracts, substances of plant origin with proven antibacterial activity.

[具有抗菌潜力的物质的研究和开发的最新情况]。
自从青霉素被广泛使用以来,抗生素一直被认为是神奇的药物,青霉素是一种有可能拯救数百万人生命的抗菌物质。不幸的是,它们的过度使用,特别是在农业和卫生保健中,导致了耐药菌株的选择和传播。无论各个国家的经济发展水平如何,抗菌素耐药性的加速发生目前是一个严重的全球性问题。因此,开发具有抗菌作用的新物质或修改现有抗菌剂的压力很大。合理的抗生素政策和抗生素管理是为了尽可能长时间地保持现有抗生素的有效性。本文旨在向读者介绍一些新近开发的具有临床应用潜力的抗菌药物:脂磷毒素,新近开发的作用于细菌细胞质膜的抗菌药物;银纳米颗粒及其对多重耐药细菌的抗菌作用,无论是纯形式还是与抗生素或光动力活性物质联合使用;一些植物提取物,植物来源的物质已被证明具有抗菌活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Klinicka mikrobiologie a infekcni lekarstvi
Klinicka mikrobiologie a infekcni lekarstvi Medicine-Infectious Diseases
CiteScore
0.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信